Arca
Skip to content
Tools
Tools

Peanut hypersensitivity

Drug research and approvals for peanut hypersensitivity: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 20 studies of peanut hypersensitivity are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 20
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 1

Recruiting now

Newest start dates first, of 20 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 1

Phase 2 7

Phase 1 or earlier 1

How its trials ended

132 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 40 whose ending is known, 55% met their primary endpoint, 5% missed it and 40% stopped early.

  • Completed, result not reported4937%
  • Ongoing3325%
  • Met its primary endpoint2217%
  • Status unknown108%
  • Stopped: other or unclear86%
  • Stopped: enrollment or feasibility43%
  • Stopped: sponsor or business decision32%
  • Missed its primary endpoint22%
  • Stopped: funding11%

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Dec 17, 2020PalforziaDefatted powder of Arachis hypogaea L., semen (peanuts)StallergenesEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.